Combating the therapy-induced resistance in tumors of the upper gastrointestinal tract

D. Liu

Combating the therapy-induced resistance in tumors of the upper gastrointestinal tract

D. Liu

Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

Abstract

Esophageal adenocarcinoma (EAC) and pancreatic ductal adenocarcinoma (PDAC) are among the most aggressive malignancies of the upper gastrointestinal tract. A key challenge in their treatment is therapy-induced resistance, which contributes to high recurrence rates and poor patient outcomes. This dissertation centers on overcoming acquired resistance by

Original language	English
Qualification	Doctor of Philosophy
Awarding Institution	University of Amsterdam
Supervisors/Advisors	van Laarhoven, Hanneke, Supervisor Bijlsma, Maarten, Supervisor van Berge Henegouwen, Mark, Co-supervisor
Award date	24 Apr 2025
Print ISBNs	9789464963601
Publication status	Published - 2025

Access to Document

https://pure.uva.nl/ws/files/229058507/Thesis.pdf

Cite this

@phdthesis{29c9fe716b364017ae01330fed14ec4c,

title = "Combating the therapy-induced resistance in tumors of the upper gastrointestinal tract",

abstract = "Esophageal adenocarcinoma (EAC) and pancreatic ductal adenocarcinoma (PDAC) are among the most aggressive malignancies of the upper gastrointestinal tract. A key challenge in their treatment is therapy-induced resistance, which contributes to high recurrence rates and poor patient outcomes. This dissertation centers on overcoming acquired resistance by",

author = "D. Liu",

year = "2025",

language = "English",

isbn = "9789464963601",

type = "Phd-Thesis - Research and graduation internal",

school = "University of Amsterdam",

}

TY - THES

T1 - Combating the therapy-induced resistance in tumors of the upper gastrointestinal tract

AU - Liu, D.

PY - 2025

Y1 - 2025

N2 - Esophageal adenocarcinoma (EAC) and pancreatic ductal adenocarcinoma (PDAC) are among the most aggressive malignancies of the upper gastrointestinal tract. A key challenge in their treatment is therapy-induced resistance, which contributes to high recurrence rates and poor patient outcomes. This dissertation centers on overcoming acquired resistance by

AB - Esophageal adenocarcinoma (EAC) and pancreatic ductal adenocarcinoma (PDAC) are among the most aggressive malignancies of the upper gastrointestinal tract. A key challenge in their treatment is therapy-induced resistance, which contributes to high recurrence rates and poor patient outcomes. This dissertation centers on overcoming acquired resistance by

M3 - Phd-Thesis - Research and graduation internal

SN - 9789464963601

ER -

Combating the therapy-induced resistance in tumors of the upper gastrointestinal tract

Abstract

Access to Document

Fingerprint

Cite this